Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/17/2001EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/17/2001EP1144631A2 Insulin-synthesis genes
10/17/2001EP1144630A2 Human cell signaling proteins (csig)
10/17/2001EP1144629A2 Further pro polypeptides and sequences thereof
10/17/2001EP1144628A2 Human vanilloid receptor gene
10/17/2001EP1144627A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b
10/17/2001EP1144626A2 Methods of monitoring hiv drug resistance
10/17/2001EP1144625A2 Nucleic-acid binding proteins
10/17/2001EP1144624A2 Human and mouse trek-1 potassium channel protein and their use
10/17/2001EP1144623A1 Method and medicament for inhibiting the expression of a defined gene
10/17/2001EP1144622A2 Polynucleotides and their application in diagnostics
10/17/2001EP1144621A2 Genetic suppressor elements against human immunodeficiency virus
10/17/2001EP1144620A1 Magnetic particles for purifying nucleic acids
10/17/2001EP1144619A1 Method of ultrafiltration
10/17/2001EP1144618A1 Method for isolating apoptosis-inducing dna sequences and detection system
10/17/2001EP1144617A2 Cancer-associated proteins
10/17/2001EP1144616A1 Method for producing antibody fragments
10/17/2001EP1144615A2 METHODS AND COMPOSITIONS FOR PRODUCING 5' ENRICHED cDNA LIBRARIES
10/17/2001EP1144614A2 33 human secreted proteins
10/17/2001EP1144613A1 Methods for making proteins containing free cysteine residues
10/17/2001EP1144612A2 Method of producing antihypercholesterolemic agents
10/17/2001EP1144611A2 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin
10/17/2001EP1144610A2 Method for carrying out the controlled post-harvest production of proteins in host organisms
10/17/2001EP1144609A2 Chimeric antisense oligonucleotides and cell transfecting formulations thereof
10/17/2001EP1144608A2 Synthetic vectors, transgenic plants containing them, and methods for obtaining them
10/17/2001EP1144607A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
10/17/2001EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001EP1144599A2 Amino-modified ribozymes
10/17/2001EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001EP1144594A1 Transgenic circulating endothelial cells
10/17/2001EP1144593A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling
10/17/2001EP1144591A2 Low oxygen culturing of cells
10/17/2001EP1144590A1 Compartmentalization of recombinant polypeptides in host cells
10/17/2001EP1144589A2 Plant histidine biosynthetic enzymes
10/17/2001EP1144587A1 Device for carrying out the cell-free synthesis of proteins
10/17/2001EP1144454A2 Modified peptides as therapeutic agents
10/17/2001EP1144451A2 Method of modulating cell differentiation or neoplastic trnasformation by altering cadherin-11 expression or function
10/17/2001EP1144450A1 Mammalian alpha-helical protein - 12
10/17/2001EP1144449A1 Reagents and methods useful for detecting diseases of the breast
10/17/2001EP1144448A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
10/17/2001EP1144447A2 Tuberculosis diagnostic test
10/17/2001EP1144444A2 Dnas encoding proteins with signal sequences
10/17/2001EP1144443A2 Human membrane transport proteins
10/17/2001EP1144442A2 Streptococcal alpha2m-binding protein
10/17/2001EP1144441A2 Disintegrin homologs
10/17/2001EP1144440A2 Neurotransmitter transporter
10/17/2001EP1144439A2 Hematopoietic regulatory factors and methods of use thereof
10/17/2001EP1144438A2 Polypeptides having acid phosphatase activity and nucleic acids encoding same
10/17/2001EP1144429A2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/17/2001EP1144092A1 Integrated portable biological detection system
10/17/2001EP1144009A2 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/17/2001EP1144006A2 Synergistic inhibition of hiv-1 fusion and attachment, compositions and antibodies thereto
10/17/2001EP1144005A1 Treatment of papillomavirus infections
10/17/2001EP1144004A1 Her-2 binding antagonists
10/17/2001EP1144002A2 A method for selecting and producing vaccine and diagnostic preparations
10/17/2001EP1143994A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
10/17/2001EP1143993A1 Method of suppressing ongoing acute allograff rejection
10/17/2001EP1143980A1 Thio-modified aptamer synthetic methods and compositions
10/17/2001EP1143976A2 Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections
10/17/2001EP1143961A2 Regulators of the ptc or smoothened pathway, compositions and uses related thereto
10/17/2001EP1143800A1 Biological control of nematodes
10/17/2001EP1143797A1 Methods for reducing adverse side effects associated with cellular transplantation
10/17/2001EP0901501B1 Nucleoside derivatives with photo-unstable protective groups
10/17/2001EP0873405A4 Expression augmenting sequence elements (ease) for eukaryotic expression systems
10/17/2001EP0870061B1 Process for detecting the expression of cd95 in cells
10/17/2001EP0832244A4 Polyphenol oxidase genes from lettuce and banana
10/17/2001EP0792367B1 A dna construct encoding the yap3 signal peptide
10/17/2001EP0692025B1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
10/17/2001EP0672120B1 Production of human monoclonal antibodies active against hepatitis b surface antigen
10/17/2001EP0617706B1 Multivalent antigen-binding proteins
10/17/2001EP0539563B1 Method of creating a transformed rice plant
10/17/2001EP0489149B1 Probes for detecting mutant p53
10/17/2001EP0471056B1 Biosynthesis of carotenoids in genetically engineered hosts
10/17/2001CN1318106A Uracile permease from arabidopsis as herbicidal target gene
10/17/2001CN1318105A Methods for down-regulating osteoprotegerin ligand activity
10/17/2001CN1318104A HIV vaccine
10/17/2001CN1318103A Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001CN1318102A OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use
10/17/2001CN1318101A New human growth differentiation factor encoding sequence and polypeptide encoded by such DNA sequence and producing method thereof
10/17/2001CN1318100A New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such DNA sequence and producing method thereof
10/17/2001CN1318098A Monolithic matrix for separating nucleic acids by reverse-phase into-pair high performance liquid chromatography
10/17/2001CN1318070A Modified i(E.coli) enterotoxin II signal peptide and microorganism expressing fusion protein of said peptide and heterologous protein
10/17/2001CN1318068A Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
10/17/2001CN1317976A Multicomponent vaccines
10/17/2001CN1317572A Method for improving quality of gramineous crops
10/17/2001CN1317571A Method for constituting genetically engineered cell strain and bacterial strain for vaccine of hepatitis B
10/17/2001CN1317570A High-lysine protein gene and method for increasing content of lysine and protein in seeds of gramineous crops
10/17/2001CN1317569A Method for preparing mammal cell kinetin synthetic inhibitory factor
10/17/2001CN1317565A Locust, microsporidian and East-Asia migratory locust strain product and its preparing process
10/17/2001CN1317560A Bleaching compsn. contg. protein enzyme
10/17/2001CN1317343A Pharmaceutical Application of mammal cell kinetin synthetic inhibitory factor
10/17/2001CN1073160C Method for sensitive detection of nuceic acids
10/17/2001CN1073159C Human kunitz-type protease inhibitors and its related method
10/17/2001CN1073158C Anti-egfr single-chain Fvs and anti-egfr antibodies
10/17/2001CN1073155C Process for producing 2-keto-L-gulonic acid
10/17/2001CN1073154C Superoxide dismutase-4
10/17/2001CN1073118C Diagnostics virus of hepatitis C
10/17/2001CN1073117C Antibiotic peptide and prodn. method and use thereof
10/16/2001USRE37411 Expression cassette for antisense expression of ribozyme